The slide deck explains the global burden of HPV-related cervical cancer, the current landscape of HPV vaccines, and the goals of the CHIC project.
Related content
![](https://www.vaccineconfidence.org/wp-content/uploads/Screenshot-2023-01-24-095501-aspect-ratio-16-9.png)
Overview The global community of practice around HPV vaccination is not formalised to cut across multiple disciplines, and thought leaders from low-…
![](https://www.vaccineconfidence.org/wp-content/uploads/3825529-aspect-ratio-16-9.jpg)
This briefing on HPV and vaccination explains the disproportionate global burden of cervical cancer on Lower Middle Income Countries and the significant barriers in the…
![](https://www.vaccineconfidence.org/wp-content/uploads/cerddu-jwkw-aspect-ratio-16-9-350x197.jpg)
Overview Human Papillomavirus (HPV) is the fourth biggest cause of mortality amongst women in Brazil according to the Pan American Health Organisation (PAHO) but COVID-19…
![](https://www.vaccineconfidence.org/wp-content/uploads/q4u9pyfz-vq-aspect-ratio-16-9.jpg)
Bassey Okposen from the National Primary Health Care Development Agency in Nigeria shares the process and the challenges being faced to…
![](https://www.vaccineconfidence.org/wp-content/uploads/pcs3mol14sk-aspect-ratio-16-9.jpg)
In 2018, the European Commission engaged the Vaccine Confidence Project to create the first “State of Vaccine Confidence in the EU” report. Since then, the VCP has conducted bi-annual research to map and monitor public attitudes to vaccines across the region and examine trends over time.
![](https://www.vaccineconfidence.org/wp-content/uploads/gzkhg_evwfy-aspect-ratio-16-9.jpg)
The aim of this qualitative study was to provide an in-depth exploration and comparison of French mothers and adolescent girls’ perceptions of the risks and benefits of HPV vaccination.